Subject
Tool
Region
FOUND 51
This research paper explores the importance of integrating mental health services into PrEP delivery, based on the experiences of a cohort of South African adolescent girls and young women. Previous research has shown that AGYW who may benefit from PrEP also face high rates of mental disorders. With a focus on integrating mental health treatment as supported by this research, PrEP adherence amongst AGYW may increase signficantly.
Adolescents and young adults living with or affected by HIV have specific needs and priorities that are currently unmet by the global HIV response. This document provides evidence-based recommendations for interventions targeted towards adolescents and young adults based on WHO guidelines.
This study assesses the merits of an economic strengthening program for HIV prevention among adolescent girls and young women. The program showed great promise, as participants gained valuable skills, increased confidence and hope, and demonstrated shifts away from risky behaviors to protective ones.
HIV prevention tools may be used earlier and more consistently during pregnancy if greater options are made available in pharmacies. This research paper quantified the preferences among Kenyan women of childbearing age regarding pharmacy-delivered HIV prevention services, which can greatly inform programmatic work and service delivery in this area.
This study demonstrated the safety and efficacy of the dapvirine vaginal ring, as well as oral PrEP regimens with tenofovir disoproxil fumarate and emtricitabine, for use during pregnancy. The safety of the oral PrEP methods has previously been established for pregnant cisgender women, but data has been limited for the dapivirine ring. This represents an important step for reducing HIV infection amongst pregnant women, who are three times more…
Lenacapavir, a twice-yearly injectable PrEP medication, was proven to be completely effective in preventing HIV infection in cisgender women. Developed by Gilead Sciences, this is the first HIV prevention drug that resulted in zero new human infections during Phase 3 trials. Lenacapavir holds great promise for the future of HIV prevention, as it represents an alternative that can mitigate challenges of adherence and stigma associated with a…
Findings provide evidence that high levels of women's empowerment were associated with safer sex practices, although this varied by country. Policymakers should incorporate empowerment indicators to address women's empowerment and HIV prevention within African couples.
This technical guide is intended to support countries in their efforts to increase their capacity to eliminate mother-to-child transmission of HIV in prison, and achieve the ultimate goal of ending AIDS as a public health threat by 2030, “leaving no one behind”.
Data highlight the role of providers as gatekeepers to female condom access in public and non-public sectors and provide support for further female condom programme expansion in South Africa and globally.
A combative relationship has been established between women’s empowerment and their risk of HIV/AIDS. The results have been consistently showing the variations of inequality in women’s empowerment across different states, consequently affecting the risk of HIV/AIDS. Ensuring sexual-rights of women should be the best strategy.
Despite the importance of women living with HIV (WLHIV) engaging in fertility plan discussions with their healthcare providers (HCPs), little research exists. This study explored perceptions surrounding fertility plan discussions between WLHIV and their HCPs in western Ethiopia, from the perspectives of both women and providers
The analysis demonstrated that adolescent girls and young women with the higher vulnerability profiles, including the impact of unequal gender norms, have increased odds of negative health outcomes and experiences. The analysis calls upon tailoring community-based HIV prevention efforts by deferentially targeting/tailoring interventions and health services for sub-populations in higher versus lower HIV vulnerability profiles. Across…
The new joint policy brief by the World Health Organization (WHO) and UNAIDS sets out the steps needed to improve and integrate HIV prevention and contraceptive services in order to reduce new HIV infections among women. This brief has been developed in response to the ECHO study which found extremely high HIV incidence rates among women frequenting contraceptive services in parts of East and Southern Africa. Recommending a woman-centered…
UNAIDS report on the global AIDS pandemic 2020 shows that women and girls in sub-Saharan Africa continue to be the most affected and accounted for 59% of all new HIV infections in the region in 2019, with 4500 adolescent girls and young women between 15 and 24 years old becoming infected with HIV every week. Young women accounted for 24% of new HIV infections in 2019, despite making up only 10% of the population in sub-Saharan Africa.
Adolescent girls and young women (AGYW) are disproportionately affected by HIV, and can face barriers to access, uptake and use of HIV prevention methods. Pre-exposure prophylaxis (PrEP) is a new, effective, individually-controlled HIV prevention tool that could benefit some AGYW. This study used qualitative, participatory, peer-led methods to explore the knowledge, views and preferences of AGYW about PrEP, HIV prevention, and sexual and…
Oral PrEP will reach women who need it if PrEP programs are well-supported and prepared. A collaboration between LVCT Health in Kenya and AVAC, through the USAID-funded OPTIONS Consortium, this video series shows how LVCT Health made changes at the site level and helped women interested in oral PrEP overcome recurring barriers to uptake and adherence.Each film in the series highlights a different theme or challenge that emerged as PrEP rolled…
This study aimed to document spending patterns of young African women receiving cash transfers as part of HIV prevention efforts. Survey data from 1,214 young women in South Africa and qualitative data from 38 participants explored how a cash transfer among young women was spent, provided they attended school. During interviews, young women discussed the significant role of cash transfers for adolescent identity, specifically with regard to…
The International Partnership for Microbicides' (IPM) 2016 Annual Report looks back at their monthly dapivirine ring to be the first microbicide and long-acting product to reduce women's risk of HIV in two Phase III trials. The report highlights the dapivirine ring and other milestones to add new tools to women's HIV prevention options.
This article evaluates the safety and efficacy of a vaginal ring containing dapivirine for the prevention of HIV infection in nearly 2,000 women of reproductive age from South Africa and Uganda. The study was a randomized, double-blind, placebo-controlled trial and it found that the dapivirine ring was not associated with any safety concerns and was associated with a lower rate of HIV-1 infection than the placebo rate.
This editorial discusses new HIV prevention methods for women and how they have fared in clinical trials, including major challenges in prevention of HIV infection of women. Dr. Adimora stresses the importance of diverse HIV intervention methods that adopt to women in different life stages and their needs.